TipRanks
Jacobson Pharma Corporation Limited (HK:2633)
:2633
Hong Kong Market
2633
Jacobson Pharma Corporation Limited
RESEARCH TOOLSreports
Want to see HK:2633 full AI Analyst Report?

Jacobson Pharma Corporation Limited (2633) Ratios

7 Followers

Jacobson Pharma Corporation Limited Ratios

HK:2633's free cash flow for Q4 2025 was HK$0.42. For the 2025 fiscal year, HK:2633's free cash flow was decreased by HK$ and operating cash flow was HK$0.23. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.37 1.37 1.88 2.59 2.68
Quick Ratio
 0.86 0.86 1.27 1.73 2.12
Cash Ratio
 0.52 0.52 0.92 1.10 1.58
Solvency Ratio
 0.36 0.37 0.38 0.37 0.19
Operating Cash Flow Ratio
 0.47 0.47 0.95 1.30 0.99
Short-Term Operating Cash Flow Coverage
 0.70 0.70 2.22 4.29 2.09
Net Current Asset Value
HK$ -237.57MHK$ -237.57MHK$ -129.77MHK$ -126.08MHK$ -366.56M
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.26 0.21 0.21 0.30
Debt-to-Equity Ratio
 0.39 0.39 0.32 0.32 0.58
Debt-to-Capital Ratio
 0.28 0.28 0.24 0.24 0.37
Long-Term Debt-to-Capital Ratio
 0.14 0.14 0.16 0.20 0.31
Financial Leverage Ratio
 1.54 1.54 1.49 1.47 1.97
Debt Service Coverage Ratio
 0.87 0.88 1.74 2.25 1.09
Interest Coverage Ratio
 11.98 11.50 10.02 4.23 5.20
Debt to Market Cap
 0.45 0.35 0.30 0.63 0.83
Interest Debt Per Share
 0.47 0.47 0.41 0.43 0.87
Net Debt to EBITDA
 1.07 1.07 0.47 0.71 1.22
Profitability Margins
Gross Profit Margin
43.19%43.19%43.94%42.27%41.84%
EBIT Margin
23.47%22.50%26.32%22.71%17.55%
EBITDA Margin
32.22%32.30%35.44%32.37%25.88%
Operating Profit Margin
23.43%22.50%26.29%22.70%17.87%
Pretax Profit Margin
23.11%23.11%23.69%17.34%19.23%
Net Profit Margin
19.22%19.22%19.08%18.19%14.06%
Continuous Operations Profit Margin
19.22%19.22%19.08%14.32%11.61%
Net Income Per EBT
83.18%83.18%80.52%104.86%73.12%
EBT Per EBIT
98.61%102.68%90.12%76.42%107.59%
Return on Assets (ROA)
8.46%8.46%8.25%7.66%4.67%
Return on Equity (ROE)
13.26%13.02%12.26%11.25%9.17%
Return on Capital Employed (ROCE)
12.92%12.41%13.41%10.70%6.75%
Return on Invested Capital (ROIC)
9.13%8.77%9.96%8.45%5.26%
Return on Tangible Assets
9.62%9.62%9.33%8.75%6.95%
Earnings Yield
15.71%12.28%12.84%23.97%13.54%
Efficiency Ratios
Receivables Turnover
 8.05 8.05 10.17 7.84 6.19
Payables Turnover
 17.46 17.46 21.22 16.39 12.94
Inventory Turnover
 2.40 2.40 2.66 2.67 2.82
Fixed Asset Turnover
 1.04 1.04 1.06 1.13 1.19
Asset Turnover
 0.44 0.44 0.43 0.42 0.33
Working Capital Turnover Ratio
 5.71 4.17 2.93 1.73 2.46
Cash Conversion Cycle
 176.80 176.80 156.13 161.19 160.07
Days of Sales Outstanding
 45.34 45.34 35.88 46.53 58.92
Days of Inventory Outstanding
 152.37 152.37 137.45 136.92 129.35
Days of Payables Outstanding
 20.90 20.90 17.20 22.27 28.21
Operating Cycle
 197.70 197.70 173.33 183.46 188.27
Cash Flow Ratios
Operating Cash Flow Per Share
 0.17 0.17 0.27 0.25 0.34
Free Cash Flow Per Share
 0.10 0.10 0.14 0.18 0.31
CapEx Per Share
 0.07 0.07 0.13 0.07 0.03
Free Cash Flow to Operating Cash Flow
 0.60 0.60 0.53 0.73 0.90
Dividend Paid and CapEx Coverage Ratio
 0.75 0.75 1.71 2.17 3.88
Capital Expenditure Coverage Ratio
 2.47 2.47 2.12 3.74 10.29
Operating Cash Flow Coverage Ratio
 0.37 0.37 0.68 0.65 0.41
Operating Cash Flow to Sales Ratio
 0.21 0.21 0.33 0.33 0.36
Free Cash Flow Yield
10.44%8.16%11.88%31.86%31.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.36 8.20 7.87 4.17 7.39
Price-to-Sales (P/S) Ratio
 1.22 1.57 1.49 0.76 1.04
Price-to-Book (P/B) Ratio
 0.83 1.06 0.96 0.47 0.68
Price-to-Free Cash Flow (P/FCF) Ratio
 9.58 12.25 8.42 3.14 3.17
Price-to-Operating Cash Flow Ratio
 5.70 7.30 4.45 2.30 2.86
Price-to-Earnings Growth (PEG) Ratio
 0.06 0.00 0.06 -0.09 0.18
Price-to-Fair Value
 0.83 1.06 0.96 0.47 0.68
Enterprise Value Multiple
 4.87 5.91 4.67 3.05 5.23
Enterprise Value
 2.46B 3.00B 2.61B 1.45B 2.42B
EV to EBITDA
 4.87 5.91 4.67 3.05 5.23
EV to Sales
 1.57 1.91 1.65 0.99 1.35
EV to Free Cash Flow
 12.27 14.95 9.37 4.09 4.13
EV to Operating Cash Flow
 7.31 8.90 4.95 3.00 3.73
Tangible Book Value Per Share
 0.96 0.96 1.04 1.02 0.78
Shareholders’ Equity Per Share
 1.16 1.16 1.24 1.24 1.43
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.19 0.17 0.16
Revenue Per Share
 0.78 0.79 0.79 0.76 0.93
Net Income Per Share
 0.15 0.15 0.15 0.14 0.13
Tax Burden
 0.83 0.83 0.81 1.05 0.73
Interest Burden
 0.98 1.03 0.90 0.76 1.10
Research & Development to Revenue
 0.00 <0.01 0.00 0.00 <0.01
SG&A to Revenue
 0.21 0.21 0.21 0.14 0.13
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 0.01 0.01
Income Quality
 1.12 1.12 1.41 1.52 2.58
Currency in HKD